↓ Skip to main content

A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target

Overview of attention for article published in Journal of Hematology & Oncology, September 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
twitter
2 tweeters

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Published in
Journal of Hematology & Oncology, September 2020
DOI 10.1186/s13045-020-00959-2
Pubmed ID
Authors

Andrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, Giorgia Simonetti

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 110 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 18 16%
Researcher 16 15%
Student > Ph. D. Student 15 14%
Student > Master 13 12%
Student > Doctoral Student 5 5%
Other 13 12%
Unknown 30 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 38 35%
Medicine and Dentistry 12 11%
Agricultural and Biological Sciences 9 8%
Chemistry 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 7 6%
Unknown 36 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2022.
All research outputs
#2,854,931
of 21,298,337 outputs
Outputs from Journal of Hematology & Oncology
#167
of 1,087 outputs
Outputs of similar age
#93,670
of 483,555 outputs
Outputs of similar age from Journal of Hematology & Oncology
#30
of 136 outputs
Altmetric has tracked 21,298,337 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,087 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 483,555 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 136 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.